Cargando…
Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
Molecular and immunohistochemical studies of genetic events on chromosome 17p were prospectively compared with conventional clinical and pathological parameters and disease behaviour at a minimum of 72 months follow-up. In a series of 91 patients with primary operable breast cancer, 37 out of 91 (41...
Autores principales: | Thompson, A. M., Crichton, D. N., Elton, R. A., Clay, M. F., Chetty, U., Steel, C. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149971/ https://www.ncbi.nlm.nih.gov/pubmed/9514060 |
Ejemplares similares
-
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
por: Eccles, D. M., et al.
Publicado: (1992) -
p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
por: Choi, S. W., et al.
Publicado: (1994) -
The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020) -
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1990) -
Δ113p53/Δ133p53: survival and integrity
por: Chen, Jun, et al.
Publicado: (2015)